Quietly, Im kind of a vain person
Clinical Results for Retatrutide According to major foreign media outlets including The Guardian on June 8 local time, Lilly in March disclosed results from a Phase 3 clinical trial of retatrutide conducted over 40 weeks in 930 adults with type 2 diabetes
The titration ramp for cagrilintide takes 16 weeks even at the conservative cadence, which extends the side-effect runway
Kidney Impairment Patients with kidney disease can usually take Hepaglide injection, but it should be used cautiously under medical supervision by individuals with Chronic Kidney Disease (CKD)
In November 2023, the FDA granted approval for Zepbound (tirzepatide) for chronic weight management in adults with obesity (body mass index 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbid condition such as hypertension, dyslipidemia, type 2 diabetes, obstructive sleep apnea, or cardiovascular disease